Detalles de la búsqueda
1.
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells.
Mol Ther
; 27(5): 933-946, 2019 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30879952
2.
Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.
Cancer Immunol Immunother
; 63(10): 1047-60, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24973179
3.
Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.
J Neurooncol
; 116(2): 237-49, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24264533
4.
Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune target.
Sci Rep
; 14(1): 11935, 2024 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38789477
5.
HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells.
Cancers (Basel)
; 13(12)2021 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34201079
6.
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes.
Cancers (Basel)
; 13(21)2021 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771738
7.
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G.
Oncotarget
; 9(5): 6536-6549, 2018 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29464090
8.
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G.
Oncoimmunology
; 6(1): e1250050, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28197367
Resultados
1 -
8
de 8
1
Próxima >
>>